Related references
Note: Only part of the references are listed.Nuclear control of lung cancer cells migration, invasion and bioenergetics by eukaryotic translation initiation factor 3F
Pauline Esteves et al.
ONCOGENE (2020)
PURA Syndrome and Myotonia
Steven P. Trau et al.
PEDIATRIC NEUROLOGY (2020)
Quantitative Proteomics Identify the Possible Tumor Suppressive Role of Protease-Activated Receptor-4 in Esophageal Squamous Cell Carcinoma Cells
Ming Wang et al.
PATHOLOGY & ONCOLOGY RESEARCH (2019)
Age-related remodelling of oesophageal epithelia by mutated cancer drivers
Akira Yokoyama et al.
NATURE (2019)
Snail2 induced E-cadherin suppression and metastasis in lung carcinoma facilitated by G9a and HDACs
Yue Hu et al.
CELL ADHESION & MIGRATION (2019)
Systemic treatment of advanced esophageal squamous cell carcinoma: chemotherapy, molecular-targeting therapy and immunotherapy
Hidekazu Hirano et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2019)
Characterization of purine-rich element binding protein B as a novel biomarker in acute myelogenous leukemia prognostication
Robert J. Kelm et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Genomic and Epigenomic Aberrations in Esophageal Squamous Cell Carcinoma and Implications for Patients
De-Chen Lin et al.
GASTROENTEROLOGY (2018)
PURA, the gene encoding Pur-alpha, member of an ancient nucleic acid-binding protein family with mammalian neurological functions
Dianne C. Daniel et al.
GENE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Somatic mutant clones colonize the human esophagus with age
Inigo Martincorena et al.
SCIENCE (2018)
Interplay between Notch1 and Notch3 promotes EMT and tumor initiation in squamous cell carcinoma
Mitsuteru Natsuizaka et al.
NATURE COMMUNICATIONS (2017)
CBX8 Suppresses Tumor Metastasis via Repressing Snail in Esophageal Squamous Cell Carcinoma
Gang Wang et al.
THERANOSTICS (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Potential diagnostic implications of miR-144 overexpression in human oesophageal cancer
Priyanka Sharma et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2016)
The roles of AKR1C1 and AKR1C2 in ethyl-3,4-dihydroxybenzoate-induced esophageal squamous cell carcinoma cell death
Wei Li et al.
ONCOTARGET (2016)
YM155, a survivin suppressant, triggers PARP-dependent cell death (parthanatos) and inhibits esophageal squamous-cell carcinoma xenografts in mice
Nan Zhao et al.
ONCOTARGET (2015)
De novo mutations in PURA are associated with hypotonia and developmental delay
Akemi J. Tanaka et al.
COLD SPRING HARBOR MOLECULAR CASE STUDIES (2015)
Identification of a secondary promoter of CASP8 and its related transcription factor PURα
Zhengwei Lin et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Whole exome sequencing in family trios reveals de novo mutations in PURA as a cause of severe neurodevelopmental delay and learning disability
David Hunt et al.
JOURNAL OF MEDICAL GENETICS (2014)
Identification of genomic alterations in oesophageal squamous cell cancer
Yongmei Song et al.
NATURE (2014)
Esophageal Carcinoma
Anil K. Rustgi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
A Switch in the Expression of Embryonic EMT-Inducers Drives the Development of Malignant Melanoma
Julie Caramel et al.
CANCER CELL (2013)
IGF2BP1 promotes mesenchymal cell properties and migration of tumor-derived cells by enhancing the expression of LEF1 and SNAI2 (SLUG)
Anne Zirkel et al.
NUCLEIC ACIDS RESEARCH (2013)
Slug Is a Predictor of Poor Prognosis in Esophageal Squamous Cell Carcinoma Patients
Md Raghibul Hasan et al.
PLOS ONE (2013)
Regulatory networks defining EMT during cancer initiation and progression
Bram De Craene et al.
NATURE REVIEWS CANCER (2013)
Lack of Pur-alpha alters postnatal brain development and causes megalencephaly
Suvi Hokkanen et al.
HUMAN MOLECULAR GENETICS (2012)
Transcriptional regulation of the human ST6GAL2 gene in cerebral cortex and neuronal cells
Sylvain Lehoux et al.
GLYCOCONJUGATE JOURNAL (2010)
Let-7g targets collagen type I α2 and inhibits cell migration in hepatocellular carcinoma
Junfang Ji et al.
JOURNAL OF HEPATOLOGY (2010)
Induction of Bicalutamide Sensitivity in Prostate Cancer Cells by an Epigenetic Purα-Mediated Decrease in Androgen Receptor Levels
XiaoMei Liu et al.
PROSTATE (2010)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
Purine-Rich Element Binding Protein (PUR) α Induces Endoplasmic Reticulum Stress Response, and Cell Differentiation Pathways in Prostate Cancer Cells
Takahiro Inoue et al.
PROSTATE (2009)
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Kornelia Polyak et al.
NATURE REVIEWS CANCER (2009)
Androgen receptor overexpression in prostate cancer linked to Purα loss from a novel repressor complex
Longgui G. Wang et al.
CANCER RESEARCH (2008)
Snail-associated epithelial-mesenchymal transition promotes oesophageal squamous cell carcinoma motility and progression
Y. Usami et al.
JOURNAL OF PATHOLOGY (2008)
The potential role of purine-rich element binding protein (PUR) α as a novel treatment target for hormone-refractory prostate cancer
Takahiro Inoue et al.
PROSTATE (2008)
Identification of purα as a new hypoxia response factor responsible for coordinated induction of the β2 integrin family
Tianqing Kong et al.
JOURNAL OF IMMUNOLOGY (2007)
Snail, ZEB and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
Hector Peinado et al.
NATURE REVIEWS CANCER (2007)
Purα is essential for postnatal brain development and developmentally coupled cellular proliferation as revealed by genetic inactivation in the mouse
K Khalili et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Comprehensive genome-wide comparison of DNA and RNA level scan using microarray technology for identification of candidate cancer-related genes in the HL-60 cell line
C Ulger et al.
CANCER GENETICS AND CYTOGENETICS (2003)
hnRNP-K and Purα act together to repress the transcriptional activity of the CD43 gene promoter
N Da Silva et al.
BLOOD (2002)
Gene expression profiling in chronic myeloid leukemia patients treated with hydroxyurea
H Bruchova et al.
LEUKEMIA & LYMPHOMA (2002)
During differentiation of the monocytic cell line U937, Purα mediates induction of the CD11c β2 integrin gene promoter
CS Shelley et al.
JOURNAL OF IMMUNOLOGY (2002)
Functional interaction between cyclin T1/cdk9 and Purα determines the level of TNFα promoter activation by Tat in glial cells
N Darbinian et al.
JOURNAL OF NEUROIMMUNOLOGY (2001)
Growth inhibition of glioblastoma cells by human Purα
N Darbinian et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2001)
During U937 monocytic differentiation repression of the CD43 gene promoter is mediated by the single-stranded DNA binding protein Purα
CS Shelley et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Deletions of PURA, at 5q31, and PURB, at 7p13, in myelodysplastic syndrome and progression to acute myelogenous leukemia
K Lezon-Geyda et al.
LEUKEMIA (2001)
Ras-induced colony formation and anchorage-independent growth inhibited by elevated expression of Pur alpha in NIH3T3 cells
SM Barr et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2001)
Regulation of the human fas promoter by YB-1, Purα and AP-1 transcription factors
A Lasham et al.
GENE (2000)
Share Paper
